Regulation of PPARα activity factors, including PPARα gene expression and protein translation, ligand specificity and availability, cofactor recruitment, corepressors or coactivators, and posttranslational modification, is an effective strategy to prevent and treat lipid disorders in kidney diseases (Bougarne et al., 2018). This evidence concerns the gene PPARA and kidney disorder.